Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Biased for benefit: Stimulating the world's most popular drug targets with more nuance

A Correction to this article was published on 01 July 2017

This article has been updated

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Change history

  • 22 June 2017

    In the June 2017 issue, the story “Biased for benefit: Stimulating the world’s most popular drug targets with more nuance” (Nat. Med. 23, 649–651, 2017) misspelled the name of Laura Bohn’s postdoctoral advisor as Mark Caron. It should be spelled Marc Caron. The error has been corrected in the HTML and PDF versions of the article.

References

  1. 1

    Boerrigter, G. et al. Circ. Heart Fail. 5, 627–634 (2012).

    CAS  Article  Google Scholar 

  2. 2

    Benjamin, E.J. et al. Circ. 135, e146–e603 (2017).

    Article  Google Scholar 

  3. 3

    Collins, S. et al. J. Cardiol. Fail. 21, 27–43 (2015).

    Article  Google Scholar 

  4. 4

    Santos, R. et al. Nat. Rev. Drug Discov. 16, 19–34 (2017).

    CAS  Article  Google Scholar 

  5. 5

    Rajagopal, K. et al. Proc. Nat. Acad. Sci. USA 103, 16284–16289 (2006).

    CAS  Article  Google Scholar 

  6. 6

    Aplin, M. et al. Basic Clin. Pharmacol. Toxicol. 100, 289–295 (2007).

    CAS  Article  Google Scholar 

  7. 7

    Kim, K.S. et al. Am. J. Physiol. Heart. Circ. Physiol. 303, H1001–H1010 (2012).

    CAS  Article  Google Scholar 

  8. 8

    Luttrell, L.M. et al. Science 283, 655–661 (1999).

    CAS  Article  Google Scholar 

  9. 9

    Pang, P.S. et al. Eur. Heart J. 10.1093/eurheartj/ehx196 (2017).

  10. 10

    Pradhan, A.A. et al. Br. J. Pharmacol. 167, 960–969 (2012).

    CAS  Article  Google Scholar 

  11. 11

    Nozaki, C. et al. J. Pharmacol. Exp. Ther. 342, 799–807 (2012).

    CAS  Article  Google Scholar 

  12. 12

    Bohn, L.M. et al. Science 286, 2495–2498 (1999).

    CAS  Article  Google Scholar 

  13. 13

    Raehal, K.M. et al. J. Pharmacol. Exp. Ther. 314, 1195–1201 (2005).

    CAS  Article  Google Scholar 

  14. 14

    Rudd, R.A. et al. MMWR Morb. Mortal. Wkly Rep. 65, 1445–1452 (2016).

    Article  Google Scholar 

  15. 15

    Manglik, A. et al. Nature 537, 185–190 (2016).

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Lewis, D. Biased for benefit: Stimulating the world's most popular drug targets with more nuance. Nat Med 23, 649–651 (2017). https://doi.org/10.1038/nm0617-649

Download citation

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing